Sudden weight gain risks fatty liver
Bariatric surgeons warn that sudden weight gain can trigger fatty liver disease and published five prevention tips — including diet changes, regular physical activity and proactive liver monitoring (hindustantimes.com). They emphasise early detection and lifestyle reversal as the best path to stop progression to NASH or fibrosis (hindustantimes.com).
Dr Sumeet Shah — chair and head of general, minimal access, bariatric and robotic surgery at Manipal Hospital, Gurugram — is the surgeon quoted in the Hindustan Times piece published April 1, 2026, warning that sudden weight gain can drive fatty‑liver risk. (hindustantimes.com) A 2023 AIIMS analysis cited by multiple Indian outlets estimated roughly 38% of Indians have non‑alcoholic fatty liver disease (NAFLD), underlining why surgeons in India are flagging rapid weight gain as a population‑level problem. (indianexpress.com) Global studies place fatty‑liver prevalence near 25–30% of adults, and major reviews note that only a minority of people with steatosis progress to cirrhosis (about 3–5% over decades), making early identification and risk stratification central to preventing advanced disease. (liverforever.org) Clinical research estimates roughly 20–25% of patients with steatosis develop inflammatory NASH/MASH, and among those with MASH a substantial fraction—around 30–40% in some series—advance to fibrosis, with fibrosis progression averaging about one stage every seven years in progressive cases. (mdpi.com) Current practice guidance from hepatology groups recommends a two‑tier monitoring approach: calculate an initial FIB‑4 score from routine bloods (age, AST/ALT, platelets) and, if elevated, proceed to noninvasive fibrosis testing such as vibration‑controlled transient elastography (FibroScan) or serum fibrosis panels for referral decisions. (aasld.org) Consensus reports and diabetes societies now call for proactive fibrosis screening in people with type 2 diabetes or metabolic risk, arguing annual primary‑care risk checks (FIB‑4) with targeted secondary testing for high or indeterminate scores to catch advanced disease earlier. (diabetesguide.acponline.org) Randomised and observational data show modest sustained weight loss lowers liver fat and inflammation (benefit seen with ~5–10% total body weight loss in many studies), and pooled analyses report that bariatric/metabolic surgery can induce biopsy‑confirmed resolution of steatosis in a majority of patients and reduce fibrosis in a substantial minority. (mayoclinic.org)
